BioCentury
ARTICLE | Company News

Management Tracks: Alector hires new president, COO and appoints R&D committee co-chairs; plus Pyxis, Translate Bio, Canaan, PMV, Janpix, Kiadis and more

December 14, 2019 12:25 AM UTC

Neuroimmunology and immuno-oncology company Alector Inc. (NASDAQ:ALEC) hired Shehnaaz Suliman as president and COO and made Richard Scheller and Thomas Südhof co-chairs of its strategic portfolio advice and review committee. Suliman was SVP of corporate development and strategy at Theravance Biopharma Inc. (NASDAQ:TBPH). Scheller, who won the 2013 Lasker Prize, is chairman of R&D at BridgeBio Pharma Inc. (NASDAQ:BBIO) and was head of therapeutics and CSO at 23andMe Inc. from 2015-2019. Südhof, a Nobel laureate, is a professor at Stanford University School of Medicine.

Immuno-oncology play Pyxis Oncology Inc. said Lara Sullivan will become CEO, succeeding founding CEO David Steinberg, and appointed her to the board. Steinberg, a general partner at Longwood Fund, will become chairman. He succeeds founding chairman John Flavin, who will remain as an independent director. Sullivan was founder and president of SpringWorks Therapeutics Inc. (NASDAQ:SWTX)...